Showing 401-410 of 2787 results for "".
MATVNews: RT002 Data From Revance Abdominoplasty Risks PFD Patch for Tattoo Removal
https://modernaesthetics.com/series/matv-news/matvnews-rt002-data-from-revance-abdominoplasty-risks-pfd-patch-for-tattoo-removal/33391/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, a look at new data for injectable RT002 from Revance and an update on abdominoplasty risks. Plus, Zwivel and CareCredit team up, and a new PFD patch eases tattoo removal. Talk back: HIPAA Security.Joining Forces: Working with Non-Aesthetic Providers to Optimize Care
https://modernaesthetics.com/ma-issues-index/2015-sept-oct/joining-forces-working-with-non-aesthetic-providers-to-optimize-care/34472/Why I agreed to build a new practice in conjunction with an ophthalmologist to offer the best range and quality of care to patients.Avoiding Complications in Cosmetic Facial Surgery
https://modernaesthetics.com/ma-issues-index/2015-sept-oct/avoiding-complications-in-cosmetic-facial-surgery/34474/Complications come in a variety of presentations. Most can be avoided or handled with the right procedures in place.MATV News: Zeltiq Introduces CoolMini; Juvederm Ultra XC Approved for Lips
https://modernaesthetics.com/series/matv-news/matv-news-zeltiq-introduces-coolmini-juv-derm-ultra-xc-approved-for-lips/33395/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, Zeltiq introduces CoolMini for submental fat, Juvéderm is approved for lips, and Syneron launches Picoway Resolve. Also in this edition, we discuss HARMONY study results and topical toxins.MATV News: FDA Approves Cellfina to Treat Cellulite; miraDry to Launch miraSmooth
https://modernaesthetics.com/series/matv-news/matv-news-fda-approves-cellfina-to-treat-cellulite-miradry-to-launch-mirasmooth/33419/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the FDA's clearance of Cellfina to treat cellulite with no loss of benefit for up to two-years as well as the new indication for miraDry for hair removal and the launch of miraSmooth. Also in this edition, FDA aPart 2: Is Your Financial Advisor Working for You?
https://modernaesthetics.com/ma-issues-index/2015-july-aug/part-2-is-your-financial-advisor-working-for-you/34505/Ask these important questions to find out what your advisor is doing for you.Non-Invasive Laser “Mega” Combinations: How to Achieve Maximum Results
https://modernaesthetics.com/ma-issues-index/2015-july-aug/non-invasive-laser-mega-combinations-how-to-achieve-maximum-results/34497/Improved outcomes and shortened downtime are just some of the advantages of multi-modality approaches to the evolving non-invasive aesthetic front.Assessing the Skin Care Opportunity
https://modernaesthetics.com/ma-issues-index/2015-july-aug/assessing-the-skin-care-opportunity/34491/No longer nebulous “lotions and potions,” today's high-quality cosmeceuticals are delivering results for patients—and practices.MATV News: Restylane Lyft FDA Approval; AAFPRS Meeting News
https://modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-fda-approval-aafprs-meeting-news/33424/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the new FDA approval for Galderma's Restylane Lyft for cheek augmentation and get insights about the upcoming AAFPRS meeting. Also in this edition, FDA approvals for BTL Vanquish and CynoSure's SculpSure, ZwivelIs Your Financial Advisor Working for You?
https://modernaesthetics.com/ma-issues-index/2015-may-june/is-your-financial-advisor-working-for-you/34527/In Part 1 of this 2-part article, experts provide important questions that might give you the answer.